obesity treatment innovation – The Milli Chronicle

Sunday, December 28, 2025

Latest:

Factual Version of a Story

Asia Latest News

NewsDesk Milli Chronicle December 27, 2025 diabetes and obesity care, Eli Lilly India, global pharma India, healthcare innovation India, India healthcare investment, India obesity drug market, Indian healthcare trends, Indian pharma market growth, injectable weight loss drugs, metabolic disease treatment, metabolic health India, Novo Nordisk India, obesity awareness India, obesity care access, obesity management solutions, obesity treatment innovation, pharma partnerships India, pharmaceutical competition India, preventive healthcare India, weight loss drugs India

Global Pharma Leaders Drive Innovation in India’s Rapidly Growing Obesity Care Market

Hyderabad – India is emerging as one of the most dynamic healthcare markets in the world, with obesity care becoming

Featured News World

NewsDesk Milli Chronicle November 8, 2025November 8, 2025 antitrust regulations, biopharma growth, Eli Lilly competition, healthcare innovation, metabolic health market, Metsera deal, Metsera shareholder meeting, Novo Nordisk withdrawal, obesity drug market, obesity treatment innovation, Pfizer $10 billion merger, Pfizer acquisition, Pfizer strategic expansion., pharmaceutical investments, U.S. biotech mergers, weight-loss drug development

Pfizer secures $10 billion Metsera deal after Novo Nordisk withdraws

Pfizer’s $10 billion acquisition of Metsera marks a major victory for the U.S. pharmaceutical giant, strengthening its position in the